Long-term efficacy of transoral endoscopic plasma resection in the treatment of early glottic laryngeal cancer and analysis of prognostic factors
- PMID: 39553225
- PMCID: PMC11560814
- DOI: 10.62347/HFTE9989
Long-term efficacy of transoral endoscopic plasma resection in the treatment of early glottic laryngeal cancer and analysis of prognostic factors
Abstract
This study aimed to evaluate the efficacy of transoral endoscopic plasma resection (TEPR) in treating early glottic laryngeal cancer (GLC) and identify prognostic factors. A retrospective analysis was conducted on the medical records of 212 patients with early GLC treated with TEPR between February 2015 and September 2018 at Dongying People's Hospital. Clinical characteristics, objective voice function changes, and clinical outcomes of the patients were analyzed. Meanwhile, Kaplan-Meier curve was plotted to assess the impact of TERP on 3- and 5-year survival in GLC patients. Additionally, univariate and multivariable logistic regression analyses were performed to assess prognostic factors for GLC recurrence, and Receiver Operating Characteristic (ROC) curves were generated to assess their predictive value for patients' prognosis. After surgery, Patients' Jitter (%), Shimmer (%) showed significant improvement from pre-surgery, in contrast to Harmonic noise ratio and maximum phonation time, which underwent a significant decrease. The study assessed success and recurrence rates over 3- and 5-year follow-up periods, revealing a disease control rate of 86.79%, with 3- and 5-year recurrence rates of 14.62% and 20.28%, respectively. Patients were categorized into favorable and unfavorable prognosis groups based on the 3-year recurrence. Univariate analysis identified significant risk factors for recurrence, including age, tumor-node-metastasis (TNM) stage, clinical stage, and cumulative anterior commissure involvement (P < 0.05). Further multivariate logistic regression confirmed the above indexes as independent risk factors impacting patient prognosis. In conclusion, TEPR effectively treats early GLC, though recurrence risk persists, with age, TNM stage, clinical stage, and anterior commissure involvement identified as prognostic risk factors, suggesting the need for targeted preventive measures in clinical practice.
Keywords: Transoral endoscopic plasma resection; glottic laryngeal cancer; prognosis; risk factor.
AJCR Copyright © 2024.
Conflict of interest statement
None.
Figures


Similar articles
-
Application of a thyroid cartilage window technique for transoral resection of early glottic cancer involving the anterior commissure.Acta Otolaryngol. 2021 Feb;141(2):197-202. doi: 10.1080/00016489.2020.1832254. Epub 2020 Oct 29. Acta Otolaryngol. 2021. PMID: 33118844
-
Oncological Outcomes of Transoral Laser Microsurgery for Early Stage Glottic Cancer with Involvement of the Anterior Commissure.Otolaryngol Head Neck Surg. 2024 Jul;171(1):172-179. doi: 10.1002/ohn.767. Epub 2024 Apr 19. Otolaryngol Head Neck Surg. 2024. PMID: 38639320
-
CO2 transoral laser microsurgery for early glottic carcinoma with anterior commissure involvement.Auris Nasus Larynx. 2023 Jun;50(3):415-422. doi: 10.1016/j.anl.2022.09.006. Epub 2022 Sep 24. Auris Nasus Larynx. 2023. PMID: 36163067
-
Efficacy of type I thyroplasty after endoscopic cordectomy for early-stage glottic cancer: Literature review.Laryngoscope. 2018 Mar;128(3):690-696. doi: 10.1002/lary.26877. Epub 2018 Jan 4. Laryngoscope. 2018. PMID: 29314074 Review.
-
The prognostic value of anterior commissure involvement in T1 glottic cancer: A systematic review and meta-analysis.Laryngoscope. 2020 Aug;130(8):1932-1940. doi: 10.1002/lary.28395. Epub 2019 Nov 13. Laryngoscope. 2020. PMID: 31721216
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140:855–860. - PubMed
-
- Locatello LG, Bruno C, Gallo O. Early glottic cancer recurrence: a critical review on its current management. Crit Rev Oncol Hematol. 2021;160:103298. - PubMed
-
- Arboleda LPA, Neves AB, Kohler HF, Vartanian JG, Candelaria LM, Borges MF, Fernandes GA, de Carvalho GB, Kowalski LP, Brennan P, Santos-Silva AR, Curado MP. Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep (Hoboken) 2023;6:e1837. - PMC - PubMed
-
- Mehlum CS, Rosenberg T, Groentved AM, Dyrvig AK, Godballe C. Can videostroboscopy predict early glottic cancer? A systematic review and meta-analysis. Laryngoscope. 2016;126:2079–2084. - PubMed
LinkOut - more resources
Full Text Sources